2013 State Rt. 59 Kent, Ohio 44240 | 330.678.0201 | 800.255.3671 | Optical: 330.673.9440
4277 Allen Rd. Stow, Ohio 44224 | 330.928.0201 | 800.548.1729 | Optical: 330.926.9663
1 Park West Drive, Akron, Ohio 44320 | 330.678.0201 | 800.255.3671
Age-Related
Macular DegenerationAge-related macular
degeneration (ARMD) is a disease that
affects central vision. It is a common
cause of vision loss in people over age
60. Only the center of your vision is
affected, so people rarely go blind from
the disease. However, ARMD can make
detailed tasks such as reading and
driving difficult.
The macula is the center of the retina
that contains many nerve cells. They
transform light into signals that tell
the brain what you are seeing. There are
2 forms of ARMD-dry and wet. Dry ARMD
affects 90% of those with the disease
and its cause is unknown. Slowly the
light sensitive cells within the macula
break down and less of the macula
functions.
Wet ARMD is responsible for severe
vision loss from the disease. It occurs
when new blood vessels under the retina
start growing toward the macula. These
new vessels tend to be fragile and often
leak blood and fluid under the macula.
This causes rapid damage and leads to
central vision loss.
People over the age of 75 have a 30% risk of developing ARMD. Smoking and family history have both been linked to increased risk. Visual symptoms include blurred or distorted vision.
TreatmentCurrently, dry ARMD cannot be treated. Wet ARMD is usually treated with conventional laser applied to the blood vessels. Some cases of wet ARMD can be treated with a new procedure called photodynamic therapy. This involves injecting a dye called Visudyne into the bloodstream. This special drug is activated by a laser beam, which causes the blood vessels to shrink. It is important to realize that any laser therapy is not a cure but a treatment to help stop further vision loss. The risk of new blood vessels growing back is relatively high.
New research in the
Age-Related Eye Disease Study (AREDS)
has shown high levels of anti-oxidants
and zinc can lower the risk of ADVANCED
ARMD by 25%. These same nutrients can
also reduce the risk of vision loss by
19%. People who are at high risk for
developing the advanced form of ARMD
should consider taking the formulation
recommended by the AREDS study.
In other studies, Lutein and Zeaxanthin,
which is a carotenoid plant substance
that is found in the macular pigment,
have also been linked to decreasing the
risk of developing ARMD in the
non-advanced form. These substances can
be found naturally in dark green leafy
vegetables and in dietary supplements.
We advise a dilated eye examination and
discussion with our doctors before
choosing a dietary supplement to help
identify your risk characteristics. Your
family physician should also be
contacted to insure these supplements
will not interfere with other
medications or systemic conditions you
may have.